Therapeutic potential of immune privileged Sertoli cells

Animal Reproduction

Volumn 12, Issue 1, 2015, Pages 105-117

  Kaur, G ^a   Thompson, L A ^a   Dufour, J M ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

Cell based gene therapy; Immune modulation; Immune privilege; Sertoli cell; Transplantation

Indexed keywords

EID: 84930635769     PISSN: 18069614     EISSN: 19843143     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Adams JD Jr, Kalivas PW, Miller CA. 1989. The acute histopathology of MPTP in the mouse CNS. Brain Res Bull, 23:1-17.
2. Adams JD Jr, Odunze IN. 1991. Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain? Biochem Pharmacol, 41:1099-1105.
3. Akhter J, Johnson, LA, Morris DL. 2009. Hepatocyte transplantation: a new approach to treat liver disorders. In: Dionigi R. (Ed.). Recent Advances in Liver Surgery. Austin, TX: Landes Bioscience. pp. 331-351.
4. Aravindan GR, Pineau CP, Bardin CW, Cheng CY. 1996. Ability of trypsin in mimicking germ cell factors that affect Sertoli cell secretory function. J Cell Physiol, 168:123-133.
5. Aravindan GR, Mruk D, Lee WM, Cheng CY. 1997. Identification, isolation, and characterization of a 41-kilodalton protein from rat germ cell-conditioned medium exhibiting concentration-dependent dual biological activities. Endocrinology, 138:3259-3268.
6. Armstrong RJ, Harrower TP, Hurelbrink CB, McLaughin M, Ratcliffe EL, Tyers P, Richards A, Dunnett SB, Rosser AE, Barker RA. 2001. Porcine neural xenografts in the immunocompetent rat: immune response following grafting of expanded neural precursor cells. Neuroscience, 106:201-216.
7. Bahar MA, Nabai L, Ghahary A. 2012. Immunoprotective role of indoleamine 2,3-dioxygenase in engraftment of allogenic skin substitute in wound healing. J Burn Care Res, 33:364-370.
8. Banfi B, Molnar G, Maturana A, Steger K, Hegedus B, Demaurex N, Krause KH. 2001. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem, 276:37594-37601.
9. Biedermann T, Boettcher-Haberzeth S, Reichmann E. 2013. Tissue engineering of skin for wound coverage. Eur J Pediatr Surg, 23: 375-382.
10. Bistoni G, Calvitti M, Mancuso F, Arato I, Falabella G, Cucchia R, Fallarino F, Becchetti A, Baroni T, Mazzitelli S, Nastruzzi C, Bodo M, Becchetti E, Cameron DF, Luca G, Calafiore R. 2012. Prolongation of skin allograft survival in rats by the transplantation of microencapsulated xenogeneic neonatal porcine Sertoli cells. Biomaterials, 33:5333-5340.
11. Brown RC, Lockwood AH, Sonawane BR. 2005. Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect, 113:1250-1256.
12. Campese AF, Grazioli P, de Cesaris P, Riccioli A, Bellavia D, Pelullo M, Padula F, Noce C, Verkhovskaia S, Filippini A, Latella G, Screpanti I, Ziparo E, Starace D. 2014. Mouse Sertoli cells sustain de novo generation of regulatory T cells by triggering the notch pathway through soluble JAGGED1. Biol Reprod, 90:53.
13. Carbone F, De Rosa V, Carrieri PB, Montella S, Bruzzese D, Porcellini A, Procaccini C, La Cava A, Matarese G. 2014. Regulatory T cell proliferative potential is impaired in human autoimmune disease. Nat Med, 20:69-74.
14. Chatelain PG, Naville D, Saez JM. 1987. Somatomedin-C/insulin-like growth factor 1-like material secreted by porcine Sertoli cells in vitro: characterization and regulation. Biochem Biophys Res Commun, 146:1009-1017.
15. De Cesaris P, Filippini A, Cervelli C, Riccioli A, Muci S, Starace G, Stefanini M, Ziparo E. 1992. Immunosuppressive molecules produced by Sertoli cells cultured in vitro: biological effects on lymphocytes. Biochem Biophys Res Commun, 186:1639-1646.
16. Dhawan A, Mitry RR, Hughes RD. 2006. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis, 29:431-435.
17. Dufour JM, Rajotte RV, Kin T, Korbutt GS. 2003. Immunoprotection of rat islet xenografts by cotransplantation with sertoli cells and a single injection of antilymphocyte serum. Transplantation, 75:1594-1596.
18. Dufour JM, Dass B, Halley KR, Korbutt GS, Dixon DE, Rajotte RV. 2008a. Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells. Cell Transplant, 17:525-534.
19. Dufour JM, Lord SJ, Kin T, Rayat GR, Dixon DE, Bleackley RC, Korbutt GS, Rajotte RV. 2008b. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice. Cell Transplant, 16:1029-1038.
20. Ekser B, Ezzelarab M, Hara H, van der Windt DJ, Wijkstrom M, Bottino R, Trucco M, Cooper DK. 2012. Clinical xenotransplantation: the next medical revolution? Lancet, 379:672-683.
21. Fallarino F, Luca G, Calvitti M, Mancuso F, Nastruzzi C, Fioretti MC, Grohmann U, Becchetti E, Burgevin A, Kratzer R, van Endert P, Boon L, Puccetti P, Calafiore R. 2009. Therapy of experimental type 1 diabetes by isolated Sertoli cell xenografts alone. J Exp Med, 206:2511-2526.
22. Fintini D, Brufani C, Cappa M. 2009. Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency. Ther Clin Risk Manag, 5:553-559.
23. França LR, Auharek SA, Hess RA, Dufour JM, Hinton BT. 2012. Blood-tissue barriers: morphofunctional and immunological aspects of the blood-testis and blood-epididymal barriers. Adv Exp Med Biol, 763:237-259.
24. Halley K, Dyson EL, Kaur G, Mital P, Uong PM, Dass B, Crowell SN, Dufour JM. 2010. Delivery of a therapeutic protein by immune-privileged Sertoli cells. Cell Transplant, 19:1645-1657.
25. Hemendinger R, Wang J, Malik S, Persinski R, Copeland J, Emerich D, Gores P, Halberstadt C, Rosenfeld J. 2005. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis. Exp Neurol, 196:235-243.
26. Hermans MH. 2011. Preservation methods of allografts and their (lack of) influence on clinical results in partial thickness burns. Burns, 37:873-881.
27. Kaur G, Long CR, Dufour JM. 2012. Genetically engineered immune privileged Sertoli cells: a new road to cell based gene therapy. Spermatogenesis, 2:23-31.
28. Kaur G, Thompson LA, Dufour JM. 2014a. Sertoli cells - Immunological sentinels of spermatogenesis. Semin Cell Dev Biol, 30C:36-44.
29. Kaur G, Thompson LA, Pasham M, Tessanne K, Long CR, Dufour JM. 2014b. Sustained expression of insulin by a genetically engineered Sertoli cell line after allotransplantation in diabetic BALB/c mice. Biol Reprod, 90:109.
30. Korbutt GS, Elliott JF, Rajotte RV. 1997. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes, 46:317-322.
31. Kumagai A, Kodama H, Kumagai J, Fukuda J, Kawamura K, Tanikawa H, Sato N, Tanaka T. 2002. Xanthine oxidase inhibitors suppress testicular germ cell apoptosis induced by experimental cryptorchidism. Mol Hum Reprod, 8:118-123.
32. Kumar A, Glaum M, El-Badri N, Mohapatra S, Haller E, Park S, Patrick L, Nattkemper L, Vo D, Cameron DF. 2011. Initial observations of cell-mediated drug delivery to the deep lung. Cell Transplant, 20:609-618.
33. Larsson LC, Czech KA, Brundin P, Widner H. 2000. Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: immune responses and functional effects. Cell Transplant, 9:261-272.
34. Larsson LC, Frielingsdorf H, Mirza B, Hansson SJ, Anderson P, Czech KA, Strandberg M, Widner H. 2001. Porcine neural xenografts in rats and mice: donor tissue development and characteristics of rejection. Exp Neurol, 172:100-114.
35. Lee WM. 2003. Acute liver failure in the United States. Semin Liver Dis, 23:217-226.
36. Lim HG, Lee HM, Oh BC, Lee JR. 2009. Cell-mediated immunomodulation of chemokine receptor 7-expressing porcine sertoli cells in murine heterotopic heart transplantation. J Heart Lung Transplant, 28:72-78.
37. Luca G, Calafiore R, Basta G, Ricci M, Calvitti M, Neri L, Nastruzzi C, Becchetti E, Capitani S, Brunetti P, Rossi C. 2001. Improved function of rat islets upon co-microencapsulation with Sertoli's cells in alginate/poly-L-ornithine. AAPS PharmSciTech, 2:48-54.
38. Luca G, Calvitti M, Mancuso F, Falabella G, Arato I, Bellucci C, List EO, Bellezza E, Angeli G, Lilli C, Bodo M, Becchetti E, Kopchick JJ, Cameron DF, Baroni T, Calafiore R. 2013. Reversal of experimental Laron Syndrome by xenotransplantation of microencapsulated porcine Sertoli cells. J Control Release, 165:75-81.
39. Mabon PJ, Weaver LC, Dekaban GA. 2000. Inhibition of monocyte/macrophage migration to a spinal cord injury site by an antibody to the integrin alphaD: a potential new anti-inflammatory treatment. Exp Neurol, 166:52-64.
40. Mai HX, Yu L, Chen LJ, Qu N, Zhao L, Wang YL, Li JT, You H, Zhang X. 2012. Renoprotective effects of cotransplanted allogeneic testicular Sertoli cells in a renal acute rejection model in rats. Exp Clin Transplant, 10:554-560.
41. Marcen R. 2009. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection. Drugs, 69:2227-2243.
42. Mital P, Kaur G, Dufour JM. 2010. Immunoprotective Sertoli cells: making allogeneic and xenogeneic transplantation feasible. Reproduction, 139:495-504.
43. Multhaup G, Schlicksupp A, Hesse L, Beher D, Ruppert T, Masters CL, Beyreuther K. 1996. The amyloid precursor protein of Alzheimer's disease in the reduction of copper(II) to copper(I). Science, 271:1406-1409.
44. National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2007. Atlanta, GA: U.S. Deaprtment of Health and Human Services, Center for Disease Control and Prevention.
45. Putnam AL, Vendrame F, Dotta F, Gottlieb PA. 2005. CD4+CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun, 24:55-62.
46. Rahman TM, Diakanov I, Selden C, Hodgson H. 2005. Co-transplantation of encapsulated HepG2 and rat Sertoli cells improves outcome in a thioacetamide induced rat model of acute hepatic failure. Transpl Int, 18:1001-1009.
47. Ramji QA, Bayrack K, Arefanian H, Marcet-Palacios M, Bleackley RC, Rajotte RV, Rayat GR. 2011. Protection of porcine islet xenografts in mice using sertoli cells and monoclonal antibodies. Transplantation, 92:1309-1315.
48. Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: 2011 transplant data. 2012. Rockville, MD: Department of Health and Human Services, Healthcare Systems Bureau, Division of Transplantation; Richmond, VA: Ann Arbor, MI: United Network for Organ Sharing, University Renal Research and Education Association. Riordan SM, Williams R. 2003. Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis, 23:203-215.
49. Ruitenberg MJ, Plant GW, Hamers FP, Wortel J, Blits B, Dijkhuizen PA, Gispen WH, Boer GJ, Verhaagen J. 2003. Ex vivo adenoviral vector-mediated neurotrophin gene transfer to olfactory ensheathing glia: effects on rubrospinal tract regeneration, lesion size, and functional recovery after implantation in the injured rat spinal cord. J Neurosci, 23:7045-7058.
50. Rust C, Gores GJ. 2000. Hepatocyte transplantation in acute liver failure: a new therapeutic option for the next millennium? Liver Transpl, 6:41-43.
51. Ryan EA, Lakey JR, Paty BW, Imes S, Korbutt GS, Kneteman NM, Bigam D, Rajotte RV, Shapiro AM. 2002. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes, 51:2148-2157.
52. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM. 2005. Five-year follow-up after clinical islet transplantation. Diabetes, 54: 2060-2069.
53. Sanberg PR, Borlongan CV, Saporta S, Cameron DF. 1996. Testis-derived Sertoli cells survive and provide localized immunoprotection for xenografts in rat brain. Nat Biotechnol, 14:1692-1695.
54. Selawry HP, Kotb M, Herrod HG, Lu ZN. 1991. Production of a factor, or factors, suppressing IL-2 production and T cell proliferation by Sertoli cell-enriched preparations. A potential role for islet transplantation in an immunologically privileged site. Transplantation, 52:846-850.
55. Selawry HP, Cameron DF. 1993. Sertoli cell-enriched fractions in successful islet cell transplantation. Cell Transplant, 2:123-129.
56. Sertoli E. 1865. Dell'esistenza di particolari cellulae ramificate nei canalicoli seminiferi del testicolo umano. Morgagni, 7:31-40.
57. Shamekh R, El-Badri NS, Saporta S, Pascual C, Sanberg PR, Cameron DF. 2006. Sertoli cells induce systemic donor-specific tolerance in xenogenic transplantation model. Cell Transplant, 15:45-53.
58. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV. 2000. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med, 343:230-238.
59. Shapiro AM. 2011. State of the art of clinical islet transplantation and novel protocols of immunosuppression. Curr Diab Rep, 11:345-354.
60. Suarez-Pinzon W, Korbutt GS, Power R, Hooton J, Rajotte RV, Rabinovitch A. 2000. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism. Diabetes, 49:1810-1818.
61. Takemoto N, Liu X, Takii K, Teramura Y, Iwata H. 2014. Transplantation of co-aggregates of Sertoli cells and islet cells into liver without immunosuppression. Transplantation, 97:287-293.
62. Tobias CA, Shumsky JS, Shibata M, Tuszynski MH, Fischer I, Tessler A, Murray M. 2003. Delayed grafting of BDNF and NT-3 producing fibroblasts into the injured spinal cord stimulates sprouting, partially rescues axotomized red nucleus neurons from loss and atrophy, and provides limited regeneration. Exp Neurol, 184:97-113.
63. Trivedi AA, Igarashi T, Compagnone N, Fan X, Hsu JY, Hall DE, John CM, Noble-Haeusslein LJ. 2006. Suitability of allogeneic sertoli cells for ex vivo gene delivery in the injured spinal cord. Exp Neurol, 198:88-100.
64. Tuszynski MH, Grill R, Jones LL, Brant A, Blesch A, Low K, Lacroix S, Lu P. 2003. NT-3 gene delivery elicits growth of chronically injured corticospinal axons and modestly improves functional deficits after chronic scar resection. Exp Neurol, 181:47-56.
65. Valdes-Gonzalez RA, Dorantes LM, Garibay GN, Bracho-Blanchet E, Mendez AJ, Davila-Perez R, Elliott RB, Teran L, White DJ. 2005. Xenotransplantation of porcine neonatal islets of Langerhans and Sertoli cells: a 4-year study. Eur J Endocrinol, 153:419-427.
66. van Paassen J, Bauer MP, Arbous MS, Visser LG, Schmidt-Chanasit J, Schilling S, Olschlager S, Rieger T, Emmerich P, Schmetz C, van de Berkmortel F, van Hoek B, van Burgel ND, Osterhaus AD, Vossen AC, Gunther S, van Dissel JT. 2012. Acute liver failure, multiorgan failure, cerebral oedema, and activation of proangiogenic and antiangiogenic factors in a case of Marburg haemorrhagic fever. Lancet Infect Dis, 12:635-642.
67. Willing AE, Othberg AI, Saporta S, Anton A, Sinibaldi S, Poulos SG, Cameron DF, Freeman TB, Sanberg PR. 1999a. Sertoli cells enhance the survival of co-transplanted dopamine neurons. Brain Res, 822:246-250.
68. Willing AE, Sudberry JJ, Othberg AI, Saporta S, Poulos SG, Cameron DF, Freeman TB, Sanberg PR. 1999b. Sertoli cells decrease microglial response and increase engraftment of human hNT neurons in the hemiparkinsonian rat striatum. Brain Res Bull, 48:441-444.
69. Wyatt CR, Law L, Magnuson JA, Griswold MD, Magnuson NS. 1988. Suppression of lymphocyte proliferation by proteins secreted by cultured Sertoli cells. J Reprod Immunol, 14:27-40.
70. Yang H, Wright JR Jr. 1999. Co-encapsulation of Sertoli enriched testicular cell fractions further prolongs fish-to-mouse islet xenograft survival. Transplantation, 67:815-820.
71. Zhao H, Sun X, Ding Q, Zhang Y. 2002. [Experimental study of sertoli cell and CTLA-4Ig's induction of immune tolerance of allogeneic renal cell]. Zhonghua Wai Ke Za Zhi, 40:259-264.